MISSISSAUGA (May 5, 2015) – Health Partners International of Canada (HPIC) announced today that Teva Canada Limited has selected them as the exclusive distributor of their medication donations.
HPIC’s mission is to increase access to medicine and to improve health in vulnerable communities around the world. Working through a network of Canadian volunteer medical mission teams and local and international humanitarian organizations, HPIC specializes in the logistics and distribution of medical aid.
“Teva Canada’s confidence in HPIC’s operations is backed up with our Health Canada Establishment Licence and accreditation by Imagine Canada’s Standards Program,” says Glen Shepherd, President of HPIC.
Teva Canada and HPIC have a long history of working together to provide needed aid around the world, but this new level of partnership is focused on maximizing reach – helping the most beneficiaries in the most efficient way. All parties will do what they do best: Teva is the world’s largest manufacturer of generic medicines; HPIC works with a humanitarian network of medical and NGO partners to move medicines where the needs are greatest.
“Donating medicines for vulnerable communities is not new for Teva Canada, said David Windross, Vice President, External Affairs of Teva Canada. “This year is the 30th anniversary of the Canadian Medicine Aid Programme (CAN-MAP), an organization founded by Leslie Dan of Novopharm Limited (now Teva Canada) to respond to donation requests for essential medicines. He believed that ‘every human being should help the sick and needy based on ability and available resources’.”
“While CAN-MAP met many urgent needs with tremendous results for 30 years, as demand grew, we realized our medication donation program needed to evolve to ensure we maximized our resources,” added Windross.
“While running CAN-MAP, Teva Canada was also a top donor to HPIC for the last decade, providing close to $40 million of essential medicine,” says Shepherd. “We are honoured to be entrusted with all the medicines that in the past would have flowed through CAN-MAP.”
All former clients and partners served by CAN-MAP are being referred to HPIC for product requests as of May 1, 2015 and have been informed of the change. “We look forward to working with them and helping them procure from a selection of donated products provided by Teva Canada and about 70 other Canadian healthcare companies,” Shepherd says.
HPIC’s mission aligns well with CAN-MAP’s mandate to “send medicine free of charge to developing countries and disaster relief areas through non-profit organizations operating hospitals and clinics around the world.” “This makes HPIC an outstanding partner to continue this vision and work,” says Windross.
HPIC is celebrating its 25th anniversary this year. The theme is “Celebrating Our Partnerships” because partnerships are key to achieving our mission. “We work with such a diverse network of partners to fulfill our mission,” says Shepherd. “For example, Teva Canada choosing to direct all their medicine donations to HPIC means that these donated medicines will be available to many organizations and health professionals and will travel to areas of need around the world.”
To procure medicines from HPIC, potential program partners must fill out an application which is reviewed through an evaluation process. Applications and more information are available at: www.hpicanada.ca
“Teva Canada recognizes that it takes funding to run our programs even though we receive donated medicines and supplies,” says Shepherd. “We are very grateful for the investment they are making in HPIC that goes along with the referrals for product requests.”
HPIC is a not-for-profit relief and development organization that delivers health and hope to the world’s most vulnerable people. We are dedicated to increasing access to medicine and improving health in the developing world without discrimination through the provision of essential medicines & medical supplies, pharmaceutical management and logistics, and capacity-building projects.
About Teva Canada Limited
Teva Canada Limited, headquartered in Toronto, has provided affordable healthcare solutions for 50 years, with nearly 200,000 prescriptions filled with our products every day. Originally Novopharm Limited, Teva Canada specializes in the development, production and marketing of high-quality generic prescription pharmaceuticals and through our branded division, Teva Canada Innovation, focuses on a diverse line of innovative products in a variety of therapeutic areas. Teva Canada employs more than 1,300 individuals, markets more than 400 products in Canada and is a subsidiary of Teva Pharmaceutical Industries Ltd., the world’s largest generic drug maker. For more information, visit: www.tevacanada.com or www.tevamakesmedicines.ca.
About Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva’s net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.
For more information, please contact:
Senior Director, Communications
Teva Pharmaceutical Industries Ltd.
Sr. Vice President, Global Corporate Reputation